Virpax Pharmaceuticals is a Pennsylvania-based biopharmaceutical company that develops non-addictive opioid compounds for pain management.
Business Model:
Revenue: $0
Employees: 2-10
Address: 1055 Westlakes Drive
City: Berwyn
State: PA
Zip: 19312
Country: US
Virpax Pharmaceuticals is a Pennsylvania-based biopharmaceutical company that develops non-addictive opioid compounds for pain management.
Contact Phone:
+16107274597
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/16/2021
IPO Valuation:
$49M
Ticker Symbol:
VRPX
IPO Price:
$10/share
Amount Raised:
$18M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2020 | Series B | $1M | 9/2021 | Post-IPO Equity | $40M | 4/2018 | Angel Round | $1.4M | 2/2018 | Equity | $1.4M | 2/2021 | Post-IPO Equity | $18M | 9/2021 | Post-IPO Equity | $40M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|